Clinical Trial Update: A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM) [Phase 2]

View source ↗

Summary

Amgen is conducting a Phase 2 study of Maridebart Cafraglutide in adults with Type 2 Diabetes Mellitus. The trial status is Active Not Recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Maridebart Cafraglutide

Snippet

Sponsor: Amgen | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 2 | Status: ACTIVE_NOT_RECRUITING